Higher concentration of CCL17 (approx. 12 pg/ml) and CCL22 (approx. 75 pg/ml) are observed in BALF of IPF patients compared to healthy volunteers, which is also considered as a likely prognostic marker for the deterioration of conditions of IPF patients (8, 117). Here, CCL22 is linked to idiopathic pulmonary fibrosis.